John Fung to Hepatitis C, Chronic
This is a "connection" page, showing publications John Fung has written about Hepatitis C, Chronic.
Connection Strength
0.721
-
Hemophilia Liver Transplantation Observational Study. Liver Transpl. 2017 06; 23(6):762-768.
Score: 0.137
-
Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C. PLoS One. 2016; 11(11):e0166998.
Score: 0.132
-
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
Score: 0.097
-
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl. 2009 Nov; 15(11):1557-63.
Score: 0.081
-
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010 Jan; 138(1):159-64.
Score: 0.080
-
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl. 2005 Nov; 11(11):1343-52.
Score: 0.061
-
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation. 2003 Nov 27; 76(10):1487-91.
Score: 0.054
-
Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.
Score: 0.046
-
The patient with chronic hepatitis C. Liver Transpl Surg. 1996 Sep; 2(5 Suppl 1):73-8.
Score: 0.033